Stay current with MiRXES
Stay informed and keep abreast with our media news.
20 Sep 2021
MiRXES, a Singapore biotechnology startup, has appointed Dr David Capes as its senior vice president and new global head of innovation on Sept 20.
8 Jul 2021
MiRXES has raised US$77 million in a Series C round, pushing to commercialise its early cancer detection test kits globally. This latest round values the biotech at over US$500 million and could pave the way for a public listing.
Media and Investor Contact
For media enquiries, please email: email@example.com